Module

Sentinel Lymph Nodes in Breast Cancer: Evolving Indications

Source: Breast Cancer Annual Update 2005

Sentinel Lymph Nodes in Breast Cancer: Evolving Indications


CME Program Director: Clifford A. Hudis, MD

Faculty:

  • Armando E. Giuliano, MD
  • Helen Mabry, MD

CME CREDIT INFORMATION

Release Date: 11/14/05

Expiration Date: 11/13/06


Physicians: maximum of 1.25 AMA PRA Category 1 Credit(s)

Registered Nurses: 1.5 Nursing CE credits

Status: Please log in to view status



Learning Objectives

Upon completion of this activity, participants should be able to:

  • Evaluate the role of sentinel lymph node biopsies vs standard axillary lymph node dissections in staging for breast cancer, based on recent findings from clinical trials
  • Review indications and contraindications for use of sentinel lymph node biopsies in early-stage breast cancer
  • Compare techniques for sentinel lymph node biopsies

Topics covered include:

  • Introduction
  • Methodology of SNB
  • Indications for SNB
  • Contraindications for SNB
  • SNB Prior to Surgery
  • SNB in Clinically Suspicious Lymph Nodes
  • SNB After Cancer Recurrence
  • SNB in Inflammatory Breast Cancer
  • SNB in Obese, Elderly, Male, or Pregnant Patients
  • Optimal Techniques for SNB
  • Potential Complications of SNB
  • Conclusions
  • Summary—Implications for Clinical Practice


Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.